Old Web
English
Sign In
Acemap
>
authorDetail
>
Kevin Kuzma
Kevin Kuzma
Genentech
Glioblastoma
Bevacizumab
Temozolomide
Cancer research
Phases of clinical research
3
Papers
16
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Correction to: Phase II study of bi-weekly temozolomide plus bevacizumab for adult patients with recurrent glioblastoma
2018
Cancer Chemotherapy and Pharmacology
Michael A. Badruddoja
Marjorie Pazzi
Abhay Sanan
Kurt Schroeder
Kevin Kuzma
Thomas Norton
Thomas Scully
Daruka Mahadevan
Michael Malek Ahmadi
Show All
Source
Cite
Save
Citations (0)
Phase II study of bi-weekly temozolomide plus bevacizumab for adult patients with recurrent glioblastoma
2017
Cancer Chemotherapy and Pharmacology
Michael A. Badruddoja
Marjorie Pazzi
Abhay Sanan
Kurt Schroeder
Kevin Kuzma
Thomas Norton
Thomas Scully
Daruka Mahadevan
Michael Malek Ahmadi
Show All
Source
Cite
Save
Citations (13)
Phase II study of biweekly temozolomide plus bevacizumab for adult patients with recurrent glioblastoma multiforme.
2010
Journal of Clinical Oncology
Michael A. Badruddoja
Marjorie Pazzi
Baldassarre Stea
Kevin Kuzma
M C Bishop
Raymond F. Carmody
Kurt Schroeder
Joachim F. Seeger
M. Marsella
Abhay Sanan
Show All
Source
Cite
Save
Citations (3)
1